Define your value strategy

Taking the right decisions at the right moments to maximize your technology’s value.

As healthcare systems around the world struggle to reconcile the increasing demand for innovative treatment, the pressure to provide access to new and innovative technologies, and increasing budget and resource constraints, value-based healthcare is fast becoming a necessity.

What we do

Inbeeo can work with you from early product development up to and including the in-line phase to optimize your value and HTA strategy. We combine our experience, expertise, and insight with our own proprietary tools to develop best-in-class strategies tailored to your objectives to:
  • Prioritize indications based on payer value

  • Evolve your market access strategy according to internal and external trends, challenges, and opportunities

  • Develop innovative agreements

  • Maximize your asset’s value throughout the lifecycle

How we do it

We help you define, collect, and interpret the data you need, turning complex information into simple overviews and strategic insights with impact.
Inbeeo applies best-in-class strategy development methods based on key proprietary tools to:
  • Provide a view on the (future) landscape and access strategy implications
  • Evaluate analogue insights in key target geographies
  • Gather payer and clinical expert feedback on your TPP
  • Rate your asset’s value relative to competitors and/or across indications
  • Identify global access opportunities
We will use this information to help you:
  • Understand your technology’s value drivers from the perspectives of relevant decision-makers across indications and geographies
  • Create a payer relevant TPP and value proposition, including the evidence base required to support it
  • Translate insights into strategies, tactics, and actions required for impactful pricing, and reimbursement

The tools we use

Our proprietary custom value assessment framework, based on Multiple-Criteria Decision Analysis (MCDA) techniques, is used to map and compare key value drivers across products and indications.

Our Payer and KOL council network of more than 100 international experts, offers a rich source of expert value feedback.

Inbeeo Global Database

Our unrivalled global database of early and alternative access pathways.

Realize the true value of your healthcare assets. Get started with Inbeeo today.